SciDev Resultados de beneficios anteriores

Pasado controles de criterios 3/6

SciDev ha aumentado sus beneficios a una tasa media anual de 38%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 8.9% anual. Los ingresos han ido creciendo a una tasa media de 41.7% al año. La rentabilidad financiera de SciDev es de 4.3%, y sus márgenes netos son de 2%.

Información clave

38.0%

Tasa de crecimiento de los beneficios

47.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	14.4%
Tasa de crecimiento de los ingresos	41.7%
Rentabilidad financiera	4.3%
Margen neto	2.0%
Última actualización de beneficios	30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Nov 13

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

Sep 30

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Dec 22

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

Nov 16

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Oct 25

When Should You Buy SciDev Limited (ASX:SDV)?

May 18

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Mar 06

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Feb 28

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

Oct 28

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Jun 09

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

Feb 02

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Sep 07

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

Feb 01

Desglose de ingresos y gastos

Cómo gana y gasta dinero SciDev. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ASX:SDV Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	109	2	20
31 Mar 24	100	1	19
31 Dec 23	91	0	17
30 Sep 23	90	0	16
30 Jun 23	90	0	16
31 Mar 23	85	0	15
31 Dec 22	81	1	13
30 Sep 22	68	0	12
30 Jun 22	56	-1	11
31 Mar 22	52	0	10
31 Dec 21	48	1	10
30 Sep 21	45	2	8
30 Jun 21	43	3	7
31 Mar 21	36	2	7
31 Dec 20	30	0	6
30 Sep 20	24	-1	5
30 Jun 20	18	-1	5
31 Mar 20	13	-1	4
31 Dec 19	8	-2	3
30 Sep 19	5	-2	3
30 Jun 19	3	-2	3
31 Mar 19	3	-1	2
31 Dec 18	2	1	2
30 Sep 18	2	1	2
30 Jun 18	2	1	2
31 Mar 18	2	0	2
31 Dec 17	2	-1	2
30 Sep 17	2	-1	1
30 Jun 17	2	-1	1
31 Mar 17	2	-1	1
31 Dec 16	2	-1	1
30 Sep 16	1	-1	1
30 Jun 16	1	0	1
31 Mar 16	1	-1	1
31 Dec 15	2	-1	1
30 Sep 15	2	-1	1
30 Jun 15	2	-1	2
31 Mar 15	2	-1	2
31 Dec 14	2	-1	2
30 Sep 14	1	-1	2
30 Jun 14	1	-1	1
31 Mar 14	1	-2	1
31 Dec 13	1	-2	1

Ingresos de calidad: SDV tiene ganancias de alta calidad.

Margen de beneficios creciente: SDV pasó a ser rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: SDV ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 38% al año.

Acelerando crecimiento: SDV ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.

Beneficios vs. Industria: SDV ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (3.9%).

SciDev Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2024 earnings: EPS misses analyst expectations

First half 2024 earnings released: EPS: AU$0 (vs AU$0 in 1H 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

First half 2023 earnings released: EPS: AU$0 (vs AU$0.014 loss in 1H 2022)

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.023 profit in FY 2021)

First half 2022 earnings: EPS exceeds analyst expectations

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

SciDev Limited, Annual General Meeting, Nov 21, 2024

Full year 2024 earnings: EPS misses analyst expectations

The Return Trends At SciDev (ASX:SDV) Look Promising

SciDev Limited (ASX:SDV) Surges 73% Yet Its Low P/S Is No Reason For Excitement

Price target increased by 29% to AU$0.54

First half 2024 earnings released: EPS: AU$0 (vs AU$0 in 1H 2023)

SciDev (ASX:SDV) Is Looking To Continue Growing Its Returns On Capital

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

SciDev Limited, Annual General Meeting, Nov 21, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.4% to AU$0.50

When Should You Buy SciDev Limited (ASX:SDV)?

Consensus EPS estimates fall by 29%

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

First half 2023 earnings released: EPS: AU$0 (vs AU$0.014 loss in 1H 2022)

Independent & Non-Executive Director recently bought AU$80k worth of stock

Price target increased to AU$0.52

SciDev Ltd Appoints Seán Halpin as Chief Executive Officer

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

SciDev Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.023 profit in FY 2021)

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Price target decreased to AU$0.75

First half 2022 earnings: EPS exceeds analyst expectations

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

SciDev Limited Ordinary Shares to Be Deleted from Other OTC

Interim Chief Financial Officer Geoff Stephenson has left the company

Price target decreased to AU$1.01

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.007 loss in FY 2020)

High number of new and inexperienced directors

Non-Executive Chairman Trevor Jones has left the company

SciDev Limited (ASX:SDV) completed the acquisition of Business of Haldon Industries.

SciDev Limited Maxiflox Contract with Eramet Subsidiary SLN

New 90-day low: AU$0.65

First half 2021 earnings released: EPS AU$0.003 (vs AU$0.002 loss in 1H 2020)

SciDev Limited Announces Executive Changes

Revenue beats expectations

SciDev Limited Names Dan O'Toole BEng to the Board as an Independent, Non-Executive Director

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

New 90-day low: AU$0.70

SciDev Limited Provides an Update on the Increased Activity Levels Within the US Oil and Gas Sector

MD, CEO & Executive Director exercised options and sold AU$517k worth of stock

New 90-day high: AU$0.90

Non-Executive Chairman recently bought AU$62k worth of stock

Non-Executive Chairman recently bought AU$62k worth of stock

Earnings released

New 90-day high - AU$0.88

SciDev Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado